Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Regenxbio Inc (RGNX)

177 + Investors. Track Smart Money conviction in RGNX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +2
Streak
3Q ▲
Buyers last Q
53%

Smart Money Signals — RGNX

Based on 178 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added RGNX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (97% of max)

97% of all-time peak
178 hedge funds hold RGNX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +7% more funds vs a year ago

fund count last 6Q
+12 new funds entered over the past year (+7% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction. The peak was reached in just 4 quarters from the low — a sharp move.
🟡

Slight buying edge — 53% buying

97 buying85 selling
Last quarter: 97 funds bought or added vs 85 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+6 vs last Q)

new funds entering per quarter
Funds opening a new RGNX position: 26 → 22 → 26 → 32. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

56% of holders stayed for 2+ years

■ 56% conviction (2yr+) ■ 26% medium ■ 18% new
99 out of 178 hedge funds have held RGNX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -4%, value -41%

Value
-40%
Shares
-3%
Last quarter: funds added -4% more shares while total portfolio value only changed -41%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

36 → 26 → 22 → 26 → 32 new funds/Q
New funds entering each quarter: 26 → 22 → 26 → 32. A growing number of institutions are discovering RGNX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 62% veterans vs 23% newcomers

■ 62% veterans ■ 15% 1-2yr ■ 23% new
Entry-cohort mix of 188 holders: 116 (62%) are 2+ year veterans, 29 entered 1–2 years ago, and 43 (23%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 33% AUM from major funds

33% from top-100 AUM funds
38 of 177 holders rank in the top 100 by AUM, accounting for 33% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.4
out of 10
Low Exit Risk
Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — RGNX

In 2026 Q1, 97 hedge funds were net buyers of RGNX (32 opened a new position, 65 added to an existing one), while 85 reduced or exited (55 trimmed, 30 sold completely) — a 53% buyer ratio, indicating a slight buying edge. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 33% of total institutional value in RGNX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +2 funds (more new holders than closures). Total institutional holders: 178.

Hedge Fund Ownership: RGNX

How many hedge funds hold RGNX — quarterly history vs. share price
Quarterly hedge fund ownership of RGNX vs. share price

Market Analysis: RGNX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: RGNX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Regenxbio Inc (RGNX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much RGNX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 76d ago
RGNX
-20.5%
XLV
+4.9%

RGNX outperformed XLV by -25.4% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 31d ago
RGNX
+16.4%
XLV
+6.0%

Since the filing became public, RGNX outperformed XLV by +10.4% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

20 top-rated funds 1 high-conviction
Consensus
5.7
/ 10
breadth
×
Elite
1.4
/ 10
conviction
Hedge Fund Positioning: RGNX
177 + Investors

Track Smart Money conviction in RGNX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 177 176 0.57%
13F Shares 40M 42M -3.72%
Total Value $354M $596M -40.7%
New Positions 31 26 +5
Increased Positions 62 63 -1
Closed Positions 30 18 +12
Reduced Positions 55 60 -5
Total Calls 6 6 -
Total Puts 5 4 25.0%
PUT/CALL Ratio 0.83 0.67 Neutral

Statistics: RGNX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

177 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in RGNX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 RGNX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 22nw, LP 2.83% 492,759 $4.1M
2 Redmile Group, LLC 2.42% 4,368,804 $36.6M
3 Lion Point Capital, LP 1.33% 26,600 $223K
4 Integral Health Asset Management, LLC 0.60% 1,500,000 $12.6M
5 ArchPoint Investors 0.44% 222,278 $1.9M
6 GSK plc 0.38% 271,456 $2.3M
7 Act Capital Management, LLC 0.37% 56,000 $469K
8 Pale Fire Capital SE 0.36% 493,726 $4.1M
9 Birchview Capital, LP 0.32% 66,270 $555K
10 Prosight Management, LP 0.27% 200,000 $1.7M
11 Voss Capital, LP 0.13% 295,787 $2.5M
12 Palogic Value Management, L.P. 0.11% 30,000 $251K
13 Nebula Research & Development LLC 0.11% 151,293 $1.2M
14 Landing Point Financial Group, LLC 0.08% 19,217 $161K
15 Militia Capital Management LLC 0.06% 33,500 $281K
16 Virtus Investment Advisers, LLC 0.05% 19,660 $165K
17 Y-Intercept (Hong Kong) Ltd 0.04% 275,021 $2.3M
18 Vestal Point Capital, LP 0.03% 108,525 $909K
19 Ionic Capital Management LLC 0.03% 41,500 $348K
20 Hennion & Walsh Asset Management, Inc. 0.02% 88,385 $741K
21 Jump Financial, LLC 0.02% 220,789 $1.9M
22 Susquehanna Portfolio Strategies, LLC 0.02% 186,601 $1.6M
23 ADAR1 Capital Management, LLC 0.02% 44,416 $372K
24 Inceptionr LLC 0.02% 10,249 $86K
25 Polymer Capital Management (US) LLC 0.02% 23,752 $199K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Regenxbio Inc (RGNX)

What does the Smart Money Trend signal show for RGNX?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added RGNX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for RGNX?

Slight buying edge — 53% buying: Last quarter: 97 funds bought or added vs 85 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for RGNX holders?

Strong quality — 33% AUM from major funds: 38 of 177 holders rank in the top 100 by AUM, accounting for 33% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held RGNX?

56% of holders stayed for 2+ years: 99 out of 178 hedge funds have held RGNX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Regenxbio Inc (RGNX) following the 2026 Q1 hedge fund 13F filings?

As of today, RGNX has moved +16.4% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of +10.4%. Since the quarter end (March 31, 2026), RGNX has gained -20.5% vs +4.9% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →